Ivermectin cream 1% is a prescription medicine applied to the skin for the treatment of inflammatory lesions of rosacea in the United States. It is a specific human-use topical formulation, not a general name for every product containing ivermectin. The 1% strength describes the concentration of the active ingredient in the cream; the prescription label and instructions identify its intended use. When reviewing a pharmacy listing, the important details are the complete product name, dosage form, strength and route of administration—not simply whether ivermectin appears in the ingredient field.
U.S. pharmacies may refer to the original branded cream, Soolantra, or to an FDA-approved product labeled ivermectin cream 1%. A generic prescription label may look different from the brand packaging, and the company named on a carton may be a manufacturer, labeler or distributor rather than the original brand owner. These differences do not by themselves establish a difference in clinical performance. Conversely, a familiar name or a past FDA approval is not proof that a specific tube is currently available from a particular pharmacy.
This guide focuses on identifying and understanding ivermectin cream 1% as a prescription product. For the wider topical category, compare topical ivermectin forms; for the original branded medicine, see Soolantra cream 1%. Readers who already have a prescription and want to understand access options can use the separate ivermectin cream pharmacy-access guide. The information below distinguishes labeled rosacea treatment from unrelated or unapproved uses without recommending a diagnosis or an individual treatment plan.
The identifying description is straightforward: ivermectin cream, 1%, for topical use, supplied as a prescription human medicine. In U.S. labeling, 1% means that each gram of cream contains 10 mg of ivermectin. This is a concentration, not a tablet strength or a measure of how much cream a person should apply. The formulation is intended for application to affected facial skin under the product instructions. It should not be swallowed, placed in the eyes or used as a substitute for another dosage form.
A prescription can be written using a brand name or an ingredient-based name, but a pharmacy still has to dispense a product consistent with the prescription and applicable substitution rules. Labels may identify a different company or package code across otherwise similar products. Consequently, the pharmacy record, package label and patient instructions are more dependable than a cropped storefront image or a listing that simply says “ivermectin topical.” The table highlights the fields that make a cream listing meaningful.
The purpose of checking these fields is product verification, not choosing among medications without medical advice. The concentration must be read together with dosage form and labeled purpose. For example, ivermectin lotion 0.5% may also appear among topical search results, yet it is a different product family with a different application site and an OTC status. If any listing blends these two descriptions, clarification from the dispensing pharmacy is necessary before relying on it.
| Product detail | What a reliable cream listing should establish | Why it matters |
|---|---|---|
| Active ingredient | Ivermectin | Distinguishes the medication from other rosacea treatments |
| Dosage form | Cream for topical use | Not an oral tablet or head-lice lotion |
| Strength | 1% (10 mg of ivermectin per gram of cream) | Identifies this particular prescription formulation |
| Labeled use | Inflammatory lesions of rosacea | Does not imply approval for every facial rash or acne |
| Legal access | Prescription (Rx) in the United States | A valid prescription is required for dispensing |
| Product identifier | Exact labeler information and NDC on the supplied package | Helps a pharmacist identify the particular listed product |
| Package quantity | Tube quantity shown for the exact product | Should match the pharmacy quote and prescription record |
| Patient directions | Instructions tied to the dispensed product and prescription | Avoids substituting directions from another formulation |
Rosacea is a clinical diagnosis with different visible features, including inflammatory bumps, persistent redness and other possible findings. The U.S. indication for ivermectin cream 1% is specifically the treatment of inflammatory lesions of rosacea, commonly described as papules and pustules. That distinction matters when a product page claims to address “rosacea” broadly. The label does not make the cream a proven solution for every form of facial redness, every flushing episode or unrelated irritation.
A clinician considers the pattern of symptoms, the skin examination, prior treatments and other possible causes of a facial eruption before deciding whether this prescription formulation is appropriate. Acne can resemble inflammatory rosacea in some situations, and perioral dermatitis may be confused with other facial conditions. Ivermectin cream 1% should not be presented as an FDA-approved acne cure or an approved treatment for perioral dermatitis. A discussion of symptom similarity is not a substitute for the label’s actual indication.
Ivermectin also appears in research and clinical discussions about Demodex mites, but a mechanistic theory does not automatically expand the approved indication. Clinical considerations and use outside approved labeling require individual professional judgment. Readers researching the condition rather than the product can review ivermectin and rosacea or the focused Demodex discussion. This product page remains anchored to the human prescription cream and its documented purpose.
A cream is a manufactured drug product that includes an active ingredient and a vehicle made from inactive ingredients. For ivermectin cream 1%, the 1% concentration identifies the amount of ivermectin in a gram of the finished preparation. It does not describe the percentage of the tube that should be applied, a recommended area of coverage or a substitute for individualized directions. Even when two tubes display the same concentration, their package presentation, excipient list, labeling company or cap design may differ.
Inactive ingredients help determine the physical characteristics of the preparation, such as its consistency and how the formulation is delivered to the skin. Their presence is important for a person with a known sensitivity to a particular ingredient, but a different excipient list is not by itself proof that one FDA-approved product is clinically better. The exact formula should be checked on the product label rather than inferred from the brand name or a retailer photograph. Anyone with a history of contact reactions can ask the pharmacist to review the dispensed product’s ingredient list.
The National Drug Code (NDC) is another useful identifying detail, but the code is not a treatment recommendation and does not prove that an item is currently in stock. Different package configurations or labelers can carry different codes. A prescription or pharmacy quote may also specify a tube quantity, which is a supply detail rather than evidence about the correct frequency of application. If a product listing omits the concentration or describes it as “ivermectin cream” without a clear label, it is reasonable to request the complete drug identity before comparing offers.
Generic ivermectin cream 1% is not a separate active ingredient from the branded reference medicine. In the United States, generic drug applications are evaluated against applicable FDA standards, including pharmaceutical equivalence and bioequivalence requirements where relevant. The FDA Orange Book records approvals and therapeutic-equivalence evaluations for eligible products. A pharmacy’s generic listing should therefore be understood through its actual approved product and labeling, rather than through the assumption that every manufacturer sells an identical-looking tube.
FDA records identify approved ivermectin cream 1% generics associated with different applicants, including Teva, Padagis and Zydus. These are examples of regulatory approvals, not a real-time inventory list or a recommendation to select a particular company. The marketed package, NDC and distributor shown by an individual pharmacy may not be the same as the original approval holder’s name. A complete pharmacy listing should establish the product identity independently of claims such as “same as brand” or “best generic.”
When the FDA assigns an applicable therapeutic-equivalence rating, the rating addresses the agency’s criteria for substitution of approved products—not whether every package has the same inactive ingredients, appearance or price. State pharmacy rules, the wording of the prescription and the prescriber’s instructions still affect what may be dispensed. For a direct brand-versus-generic assessment, consult Soolantra versus generic ivermectin cream; this section explains the generic product category rather than ranking individual generics.
Soolantra is the recognized U.S. brand name associated with the prescription ivermectin 1% rosacea cream. A generic package may instead present the ingredient name prominently, with another company identified as the labeler. Both labels refer to cream containing ivermectin at the stated strength, but the exact approved product and its regulatory record must still be verified. A brand name can be helpful in identifying what a patient was prescribed; it is not a reliable stand-in for a verified in-stock item.
There is also a difference between asking whether a generic exists and asking which product a particular prescription permits the pharmacy to dispense. The first question concerns regulatory approval. The second involves product availability, prescription wording, pharmacy practice and state-specific substitution requirements. When a prescription says Soolantra, a pharmacist can explain whether an appropriate approved generic may be dispensed and whether prescriber authorization is necessary in that situation. No website description can guarantee a substitution without the actual prescription and dispensing context.
Patients sometimes compare products because they have used one tube before and a refill is presented under a different name. In that case, the useful checks are active ingredient, concentration, topical dosage form, exact product identity and patient directions. Questions about branded product labeling belong in the Soolantra brand guide, while a dedicated Soolantra price guide addresses durable brand-cost factors without assuming a current advertised offer.
Ivermectin cream 1% for rosacea is a prescription medicine in the United States. A clinician determines whether it is appropriate and, if so, issues a prescription containing the relevant medication and instructions. The pharmacy checks the prescription against its dispensing requirements and may clarify missing or inconsistent details with the prescriber. This differs from buying an OTC cosmetic cream or an OTC lice treatment: the word “topical” alone does not remove the prescription requirement.
Before a fill, a patient may ask which ivermectin cream 1% product the pharmacy can supply, whether the prescription permits a generic and what package quantity is being quoted. These questions help distinguish a true medication listing from an advertisement for a vaguely described product. A pharmacy can also explain how a prior authorization request or other benefit rule may affect processing, without promising that an insurer will cover the medicine. A doctor’s authorization and a pharmacy’s ability to obtain stock are separate matters.
For the detailed steps after a valid prescription is issued, consult the separate guide to obtaining ivermectin cream 1% through a pharmacy. Readers with questions about medical and legal prescription categories can review U.S. ivermectin prescription requirements. Neither reference changes the basic product fact: a pharmacy should identify the human-use prescription cream precisely rather than use a generic “ivermectin for skin” description.
U.S. labeling for ivermectin cream 1% describes topical use on affected areas of the face, generally once daily, with the cream spread in a thin layer while avoiding the eyes and lips. Those are product-label facts, not a personalized instruction to start or modify treatment. The prescriber and the patient instructions accompanying the dispensed product govern individual use. Applying more cream, changing the frequency or combining medicines without advice is not a dependable way to speed up improvement.
Because rosacea is a variable condition, follow-up may be needed to assess whether inflammatory lesions are responding as expected and whether irritation or other symptoms require attention. The label’s clinical-study results describe outcomes observed in studied groups; they do not guarantee a particular timeline or result for every patient. Likewise, a prescription for this cream does not establish that all redness, burning or flushing is caused by rosacea. New or worsening findings deserve reassessment rather than an unsupported change of product.
Questions about cleanser, moisturizer, sunscreen and another prescribed facial treatment are best considered in the context of the person’s whole skin-care regimen. Different products may have different instructions for use on the same area. A pharmacist can review the cream’s official instructions, and the treating clinician can address whether concurrent treatments or persistent symptoms warrant a plan adjustment. The product guide therefore explains what the label says without turning that information into an individualized regimen.
Ivermectin cream can cause local adverse reactions. U.S. prescription labeling describes skin burning sensation and irritation among reactions observed in clinical trials, and the full product labeling contains additional safety information relevant to particular situations. A person who experiences significant irritation, a suspected allergic reaction or symptoms that seem unusual should consult a healthcare professional. Pregnancy, breastfeeding, pediatric use and known ingredient sensitivities are examples of questions that should be reviewed against the exact product label and medical circumstances.
The cream is not meant to be taken by mouth, used in the eyes or applied internally. Veterinary ivermectin preparations, compounded products of uncertain identity and unlabeled internet mixtures are not alternatives to a verified U.S. human prescription cream. A seller’s claim that a product contains the same active ingredient does not establish comparable formulation, quality, regulatory approval or appropriate use. For a broader discussion of product-specific precautions, see ivermectin safety information.
Acne, perioral dermatitis and other facial eruptions may appear in search results for ivermectin cream, but those search phrases are not its FDA-approved indication. Demodex-related discussions should also be distinguished from a promise of approved mite treatment for any skin condition. This page does not present ivermectin cream 1% as a general acne medication, a cure for perioral dermatitis or an appropriate self-treatment for an undiagnosed rash. Clinical evaluation remains essential when the diagnosis or treatment choice is uncertain.
It is a prescription topical medicine indicated for the treatment of inflammatory lesions of rosacea. The indication concerns a particular manifestation of rosacea, not every episode of facial redness or irritation. Whether a person has rosacea and should use this medicine is a clinical decision based on their medical circumstances.
No. The U.S. human-use ivermectin cream 1% for rosacea is a prescription product. The existence of an OTC ivermectin lotion 0.5% for head lice does not make the rosacea cream OTC. Pharmacy dispensing requires a valid prescription consistent with applicable rules.
They contain the same active ingredient at the stated 1% strength when comparing the relevant FDA-approved products. An approved generic may be evaluated for therapeutic equivalence to the reference medicine, but its packaging, inactive ingredients and labeler can differ. A pharmacist can verify the specific product and whether substitution is permitted.
It is the concentration of ivermectin in the finished cream: 10 mg of ivermectin per gram of product. It is not a recommended application amount, treatment duration or substitute for the directions issued with a prescription. The exact cream and its label should be identified before interpreting the number.
Acne is not the FDA-labeled indication for ivermectin cream 1%. Certain inflammatory facial conditions can look similar, and a clinician should distinguish acne from rosacea or other disorders. A product marketed as an acne cure on the basis of ivermectin alone goes beyond its approved cream indication.
Perioral dermatitis is not the FDA-approved indication for ivermectin cream 1%. Treatment outside approved labeling is a clinician-led decision that depends on diagnosis, medical evidence and individual circumstances. A person should not assume that a cream prescribed for rosacea will be suitable for a different facial rash.
No. They have different strengths, dosage forms, labeled purposes and pharmacy access requirements. Prescription cream 1% is for inflammatory lesions of rosacea, while OTC lotion 0.5% is a head-lice product. The shared active ingredient does not make the two formulations substitutes.
No. FDA approval establishes regulatory status, not real-time commercial inventory. A particular pharmacy may have access to some labeled products but not others. A product-specific stock or ordering question must be answered by the pharmacy without relying on an approval listing as evidence of availability.
Confirm the exact medication name, cream dosage form, 1% concentration, prescription directions, labeled product identity and package quantity. If the name differs from a previous tube or the prescribed brand, ask the pharmacist whether it is an appropriate approved generic and whether substitution is permitted.
The exact product and package, brand or generic status, pharmacy, insurance terms and payment method can affect the final charge. A reliable comparison uses a current licensed-pharmacy quote for the specific product rather than an old online price or an advertised discount that may not apply to the prescription.